Want to explore microdosing
Eli Lilly responded more aggressively through its LillyDirect platform
It uses liraglutide, another GLP-1 receptor agonist, to promote weight loss and appetite control. Mounjaro, a dual GIP/GLP-1 receptor agonist, ranges from $1,000 per refill when not covered by insurance
While the early findings are exciting, these therapies should not be prescribed based on brain health claims alone
Initially designed for controlling blood sugar levels, medications like Ozempic (semaglutide), and Mounjaro (tirzepatide) have proven to deliver impressive weight-loss results, leading to their swift acceptance beyond diabetes treatment
This knowledge has driven the development of vaccines that prevent infection with some cancer-causing strains of HPV and the development of a clinical test that detects cancer-causing HPV strains in cervical cells